In plain words
as of 20 Nov 2026Over 1 year it returned 17.0%, above the middle Index Funds (Equity) fund (0.5%) by 16.5 points.
The deepest fall was −9.3% (Aug 2026 to Oct 2026); it recovered in 17 days.
Of every 1-year period since launch, 0% ended below where they started. The middle 1-year result was 12.0%.
This is a Regular plan: it pays a distributor commission inside its fee. The Direct plan holds the same portfolio at a lower cost.
Key facts
- Fund house
- DSP Mutual Fund
- Category
- Index Funds (Equity) (SEBI)
- Plan & option
- Regular · Growth
- Benchmark i
- NIFTY Healthcare TRI (tracked via ICICI Prudential Nifty Healthcare ETF)
- First NAV
- 20 Jun 2025 · 1.4 years of history · 349 NAVs
- AMFI code
- 153592
- ISIN
- INF740KA1WC7
- Expense ratio i
- 1.07%
- Fund size
- ₹26 Cr
How ₹100 grew
Returns
Up to 1 year: total change. Longer: yearly (CAGR) i| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch | |
|---|---|---|---|---|---|---|---|---|---|---|
| This fund | +12.24% | +5.90% | +10.14% | +19.00% | +16.97% | — | — | — | — | +15.80% |
| NIFTY Healthcare TRI* | +12.35% | +6.16% | +10.59% | +20.00% | +18.07% | +20.97% | +15.83% | — | — | — |
| Index Funds (Equity) middle fund i | +8.17% | −0.17% | +5.81% | +1.26% | +0.50% | +10.76% | +8.57% | +12.10% | +12.82% | — |
Category middle = median Regular Growth fund in Index Funds (Equity) (112 funds with 3 years). * Benchmark approximated by ICICI Prudential Nifty Healthcare ETF with its expense ratio added back. Blank means not enough history, never zero.
Risk and risk-adjusted return
Last 36 months · risk-free rate 6.5%Against its benchmark
NIFTY Healthcare TRI · 36 monthly returnsThe worst it has been
Every 1-year period i
One 5-year number depends on its start date. These show what happened across every start date in the fund's life.
What it holds
filed for 31 Oct 2026Asset mix
Company size
How concentrated
Largest sector: Pharmaceuticals & Biotechnology at 81.8%.
Largest holdings
| Holding | Sector | Weight |
|---|---|---|
| Sun Pharmaceutical Industries Limited | Pharmaceuticals & Biotechnology | 16.32% |
| Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | 10.78% |
| Laurus Labs Limited | Pharmaceuticals & Biotechnology | 8.12% |
| Apollo Hospitals Enterprise Limited | Healthcare Services | 7.54% |
| Dr. Reddy's Laboratories Limited | Pharmaceuticals & Biotechnology | 7.15% |
| Cipla Limited | Pharmaceuticals & Biotechnology | 6.73% |
| Torrent Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 5.89% |
| Max Healthcare Institute Limited | Healthcare Services | 5.55% |
| Lupin Limited | Pharmaceuticals & Biotechnology | 4.23% |
| Aurobindo Pharma Limited | Pharmaceuticals & Biotechnology | 4.03% |
| Fortis Healthcare Limited | Healthcare Services | 3.47% |
| Glenmark Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 3.00% |
| Zydus Lifesciences Limited | Pharmaceuticals & Biotechnology | 2.68% |
| Alkem Laboratories Limited | Pharmaceuticals & Biotechnology | 2.67% |
| Mankind Pharma Limited | Pharmaceuticals & Biotechnology | 2.45% |
| IPCA Laboratories Limited | Pharmaceuticals & Biotechnology | 2.32% |
| Gland Pharma Limited | Pharmaceuticals & Biotechnology | 2.14% |
| Biocon Limited | Pharmaceuticals & Biotechnology | 2.13% |
| Krishna Institute Of Medical Sciences Limited | Healthcare Services | 1.62% |
| Abbott India Limited | Pharmaceuticals & Biotechnology | 1.16% |
Sectors
What the manager did last month
30 Sep 2026 → 31 Oct 2026A holding's value moves with its price; only a change in the number of shares is a decision. These lists use share counts. A split or bonus also changes share counts, so check sudden round multiples.
Added to 20
Against similar funds
Top Index Funds (Equity) Regular Growth funds by return. A sort by one past number, not a recommendation.
| Fund | Return | Volatility | Sharpe | Alpha | Beta | Deepest fall | Stars |
|---|---|---|---|---|---|---|---|
| ICICI Prudential NASDAQ 100 Index Fund ICICI Pru | +22.71% | 18.5% | 0.88 | — | — | −30.20% | ★★★★★ |
| ICICI Prudential Nifty Pharma Index Fund ICICI Pru | +20.87% | 14.9% | 0.96 | −0.93% | 1.00 | −16.78% | ★★★★★ |
| Motilal Oswal S&P 500 Index Fund Motilal Oswal | +20.79% | 13.3% | 1.07 | — | — | −20.14% | ★★★★★ |
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Edelweiss | +19.84% | 11.2% | 1.19 | — | — | −16.69% | ★★★★★ |
| ICICI Prudential Nifty Auto Index Fund ICICI Pru | +19.55% | 21.3% | 0.61 | −0.80% | 1.00 | −28.51% | ★★★★★ |
| Motilal Oswal BSE Enhanced Value Index Fund Motilal Oswal | +19.23% | 21.5% | 0.59 | — | — | −21.81% | ★★★★★ |
| Motilal Oswal BSE Enhanced Value Index Fund Motilal Oswal | +18.43% | 21.5% | 0.56 | — | — | −22.11% | ★★★★★ |
| UTI Nifty 500 Value 50 Index Fund UTI | +18.17% | 19.7% | 0.59 | — | — | −22.84% | ★★★★★ |
| Navi Nifty India Manufacturing Index Fund Navi | +16.77% | 17.2% | 0.60 | — | — | −23.35% | ★★★★★ |
| Kotak Nifty Next 50 Index Fund Kotak | +16.23% | 20.3% | 0.48 | −0.19% | 1.00 | −26.49% | ★★★★★ |
| DSP Nifty Healthcare Index Fund DSP | — | — | — | — | — | −9.29% | Not rated |
Compare side by side with another Index Funds (Equity) fund
All plans and options
| Scheme | NAV | AMFI code |
|---|---|---|
| Direct · Growth | ₹12.4357 | 153594 |
| Direct · IDCW | ₹12.4357 | 153593 |
| Regular · Growth | ₹12.3167 | 153592 |
| Regular · IDCW | ₹12.3167 | 153595 |
About Index Funds (Equity) funds
- The rule
- Copies an equity index such as NIFTY 50; low cost, no stock picking.
- Who it can suit
- Investors who want the market's return at low cost.
- Typical holding period
- 5 years or more
Questions people ask
What is the NAV of DSP Nifty Healthcare Index Fund?
₹12.3167 as of 20 Nov 2026, from AMFI's daily NAV file. NAVs are published once every business day after markets close.
Direct or Regular: what is the difference?
Same portfolio. Regular pays a distributor commission inside its fee, so it returns a little less every year.
Growth or IDCW?
Growth reinvests everything. IDCW pays some out, so its NAV drops after each payout and its NAV-based return understates what investors received.
How are these numbers calculated?
Every figure is computed by Growth from the fund's published NAV history. See How we calculate.